Top Markets
#1 Cortex Cortex +173.60%
#2 GEKKO GEKKO +51.79%
#3 Audiera Audiera +20.32%
#4 Helium Helium +19.19%
#5 ADO Protocol ADO Protocol +17.84%
#6 Pons Pons +15.28%
#7 TENDIES TENDIES +13.31%
#8 o1.exchange o1.exchange +13.30%
#9 Ontology Gas Ontology Gas +13.20%
#10 aelf aelf +9.81%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Daan Gene Co., Ltd. Daan Gene Co., Ltd.

Daan Gene Co., Ltd.

002030
Rank in Stocks #8888
Daan Gene Co., Ltd. specializes in the research, development, manufacturing,... Daan Gene Co., Ltd. specializes in the research, development, manufacturing, and commercialization of clinical diagnostic reagents and instruments. The company's extensive product portfolio encompasses advanced solutions such as fluorescence quantitative PCR products, time-resolved series diagnostics, enzyme-linked immunoassay (EIA) kits, various diagnostic instruments, and specialized scientific research services. Beyond product offerings, the company extends its expertise to provide comprehensive medical examination and health management services. These encompass a wide range of offerings, from genetic susceptibility gene testing and tumor marker analysis to crucial cervical cancer screening and general routine physical examinations, alongside other personalized health support. Established in 2001, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It is presently headquartered in Guangzhou, located in the People's Republic of China.
Share Price
$0.81586517
Last synced: 2026-08-28
Market Cap
$1.15B
Change (1 day)
0.18%
Change (1 year)
-13.81%
Country
CN
Trade Daan Gene Co., Ltd. (002030)

Category

Healthcare
P/S ratio for Daan Gene Co., Ltd. (002030)
P/S ratio as of 2026 TTM: 0
According to Daan Gene Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Daan Gene Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH